Rambus' cash-heavy balance sheet and memory technology lead to growth. Find out why RMBS stock is an appealing buy despite cyclicality and competition risks.
Record-high quarterly revenue of NOK 544 million in the third quarter of 2024, up 43% from the third quarter of 2023. Year-to-date (YTD) revenue as per the third quarter of 2024 stood at NOK 1,480 ...
Fisher & Paykel is well-positioned to benefit from long-term growth prospects in hospital and home respiratory care. Increasing adoption of nasal high flow, or NHF, therapy in the hospital division is ...
Checking a company's vital signs before investing in its stock for dividend income is essential. Johnson & Johnson is among the world's healthiest companies. The company has a pristine balance sheet.